Skip to main content
SpringerLink
Log in

Hyponatremia related to medical anticancer treatment

  • Review Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Hyponatremia is a common potential complication in cancer patients. It can be related to anticancer medical therapy. Vincristine, vinblastine, cisplatin and cyclophosphamide are the chemotherapeutic agents most frequently associated with hyponatremia. More recently, analogs such as carboplatin and ifosfamide have also been. incriminated. Hyponatremia is also associated with new immunomodulators (interferon, interleukin-2 and levamisole) and monoclonal antibodies. The mechanism by which all these drugs act on the sodium steady state is only partially known. The syndrome of inappropriate antidiuretic hormone secretion is described secondary to vinca alkaloids and cisplatin and possibly with alkylating agents. Renal salt wasting is described with platinum compounds.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Antony A, Robinson WA, Roy C, Pelander W, Donohue R (1980) Inappropriate antidiuretic hormone secretion after high dose vinblastine. J Urol 123:783–784

    PubMed  Google Scholar 

  2. Bartter FC, Schwartz WB (1967) The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 42:790–806

    PubMed  Google Scholar 

  3. Bennett CL, Vogelzang NJ, Ratain MJ, Reich SD (1986) Hyponatremia and other toxic effects during a phase I trial of recombinant human gamma interferon and vinblastine. Cancer Treat Rep 70:1081–1084

    PubMed  Google Scholar 

  4. Bissett D, Cornford EJ, Sokal M (1989) Hyponatraemia following cisplatin chemotherapy. Ann Oncol 28:823

    Google Scholar 

  5. Bressler RB, Huston DP (1985) Water intoxication following moderatedose intravenous cyclophosphamide. Arch Intern Med 145:548–549

    PubMed  Google Scholar 

  6. Burdman JA (1966) A note on the selective toxicity of vincristine sulfate on chick-embryo sensory ganglia in tissue culture. J Natl Cancer Inst 37:331

    PubMed  Google Scholar 

  7. Callewart CC, Minchew JT, Kanim LE, Tsai YC, Salehmoghaddam S, Dawson EG, Delamarter RB (1994) Hyponatremia and syndrome of inappropriate antidiuretic hormone secretion in adult spinal surgery. Spine 19:1674–1679

    PubMed  Google Scholar 

  8. Cantwell BMJ, Idle M, Millward MJ, Hall G, Lind MJ (1990) Encephalopatby with hyponatremia and inappropriate arginine vasopressin secretion following an intravenous ifosfamide infusion. Ann Oncol 1:232

    PubMed  Google Scholar 

  9. Courjault-Gautier F, Hoet D, Leroy D, Toutain HJ (1994) Dissimilar alterations of sodium-coupled uptake by platinum-coordination complexes in renal proximal tubular cells in primary culture. J Pharmacol Exp Ther 270:1097–1104

    PubMed  Google Scholar 

  10. Courjault-Gautier F, Le Grimmelec C, Giocondi MC, Toutain HJ (1995) Modulation of sodium-coupled uptake and membrane fluidity by cisplatin in renal proximal tubular cells in primary culture and brush-border membrane vesicles. Kidney Int 47:1048–1056

    PubMed  Google Scholar 

  11. Culine S, Ghosn M, Droz JP (1990) Inappropriate antidiuretic hormone secretion induced by ifosfamide. Eur J Cancer 26:922

    Google Scholar 

  12. Cutting HO (1971) Inappropriate secretion of antidiuretic hormone secondary to vincristine therapy. Am J Med 51:269–271

    PubMed  Google Scholar 

  13. Decaux G, Unger J, Brimioulle S, Mockel J (1982) Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Rapid correction with urea, sodium chloride, and water restriction therapy. JAMA 247:471–474

    PubMed  Google Scholar 

  14. Decaux G, Prospert F, Penninckx R, Namias B, Soupart A (1993) 5-year treatment of the chronic syndrome of inappropriate secretion of ADH with oral urea. Nephron 63:468–470

    PubMed  Google Scholar 

  15. DeFronzo RA, Braine H, Colvin M, Davis PJ (1973) Water intoxication in man after cyclophosphamide therapy. Time course and relation to drug activation. Ann Intern Med 78:861–869

    PubMed  Google Scholar 

  16. El Weshi A, Thieblemont C, Cottin V, Barbet N, Catimel G (1995) Cisplatin-induced hyponatremia and renal sodium wasting. Acta Oncol 34:264–265

    PubMed  Google Scholar 

  17. Escuro RS, Adelstein DJ, Carter SG (1992) Syndrome of inappropriate secretion of antidiuretic hormone after infusional vincristine. Cleve Clin J Med 59:643–644

    PubMed  Google Scholar 

  18. Färkkilä M, Iivanainen M, Roine R, Bergström L, Laaksonen R, Niemi ML, Cantell K (1984) Neurotoxic and other side effects of high-dose interferon in amyotrophic lateral sclerosis. Acta Neurol Scand 69:42–46

    Google Scholar 

  19. Fine RN, Clarke RR, Shore NA (1966) Hyponatremia and vincristine therapy. Syndrome possibly resulting from inappropriate antidiuretic hormone secretion. Am J Dis Child 112:256–259

    PubMed  Google Scholar 

  20. Frahm H, Hulst M von (1988) Increased secretion of vasopressin and edema formation in high dosage me thotrexate therapy. Z Ges Inn Med 43:411–414

    PubMed  Google Scholar 

  21. Fraschini G, Recchia F, Holmes FA (1987) Syndrome of inappropriate antidiuretic hormone secretion associated with hepatic arterial infusion of vinblastine in three patients with breast cancer. Tumori 73:513–516

    PubMed  Google Scholar 

  22. Fukabori T, Nakamura T, Kida T, Fujita Y, Goto T, Hiramori N, Fujii T, Iwasaki Y, Nakagawa M (1991) Syndrome of inappropriate antidiuretic hormone secretion following cisplatinum and vindesine administration in a patient with squamous cell carcinoma of the lung. Gan To Kagaku Ryoho 18:1213–1216

    PubMed  Google Scholar 

  23. Giaccone G, Donadio M, Ferrati P, Ciuffreda L, Bagatella M, Gaddi M, Calciati A (1985) Disorders of serum electrolytes and renal function in patients treated with cis-platinum on an outpatient basis. Eur J Cancer Clin Oncol 21:433–437

    PubMed  Google Scholar 

  24. Ginsberg SJ, Comis RL, Fitzpatrick AV (1977) Vinblastine and inappropriate ADH secretion (letter). N Engl J Med 296:941

    Google Scholar 

  25. Ginsberg SJ, Comis RL, Miller M (1982) The development of hyponatremia following combination chemotherapy for metastatic germ cell tumors. Med Pediatr Oncol 10:7–14

    PubMed  Google Scholar 

  26. Gonzales-Vitale JC, Hayes DM, Cvitkovic E, Sternberg SS (1977) The renal pathology in clinical trials of cis-platinum (II) diamminedichloride. Cancer 39:1362–1371

    PubMed  Google Scholar 

  27. Greenbaum-Lefkoe B, Rosenstock JG, Belasco JB, Rohrbaugh TM, Meadows AT (1985) Syndrome of inappropriate antidiuretic hormone secretion. A complication of highdose intravenous melphalan. Cancer 55:44–46

    PubMed  Google Scholar 

  28. Gross J, Steinberg SM, Reilly JG, Bliss DP, Brenan J, Tram Le P, Simmons A, Phelps R, Mulshine JL, Ihde DC, Johnson BE (1993) Atrial natriuretic factor and arginine vasopressin production in tumor cell lines from patients with lung cancer and their relationship to serum sodium. Cancer Res 53:67–74

    PubMed  Google Scholar 

  29. Hainsworth JD, Workman R, Greco FA (1983) Management of the syndrome of inappropriate antidiuretic hormone secretion in small cell lung cancer. Cancer 51:161–165

    PubMed  Google Scholar 

  30. Harlow PJ, DeClerck YA, Shore NA, Ortega JA, Carranza A, Heuser E (1979) A fatal case of inappropriate ADH secretion induced by cyclophosphamide therapy. Cancer 44:896–898

    PubMed  Google Scholar 

  31. Hutchison FN, Perez EA, Gandara DR, Lawrence HJ, Kaysen GA (1988) Renal salt wasting in patients treated with cisplatin. Ann Intern Med 108:21–25

    PubMed  Google Scholar 

  32. Istre O, Skajaa K, Schjoensby AP, Forman A (1992) Changes in serum electrolytes after transcervical resec tion of endometrium and submucous fibroids with use of glycine 1.5% for uterine irrigation. Obstet Gynecol 80:218–222

    PubMed  Google Scholar 

  33. Izquierdo R, Leinung M (1993) Hyponatraemia secondary to administration of ifosfamide. Eur J Cancer 29A:2072–2073

    PubMed  Google Scholar 

  34. Kennedy PGE, Mitchell DM, Hoffbrand BI (1978) Severe hyponatremia in hospital inpatients. BMJ 2:1251–1253

    PubMed  Google Scholar 

  35. Kim YK, Byun HS, Kim YH, Woo JS, Lee SH (1995) Effect of cisplatin on renal function in rabbits: mechanism of reduced glucose reabsorption. Toxicol Appl Pharmacol 130:19–26

    PubMed  Google Scholar 

  36. Kurtzberg J, Dennis VW, Kinney TR (1984) Cisplatinum-induced renal salt wasting. Med Pediatr Oncol 12:150–154

    PubMed  Google Scholar 

  37. Lammers PJ, White L, Ettinger LJ (1984) Cis-platinum-induced renal sodium wasting. Med Pediatr Oncol 12:343–346

    PubMed  Google Scholar 

  38. Lee YK, Shin DM (1992) Renal salt wasting in patients treated with highdose cisplatin, etoposide, and mitomycin in patients with advanced nonsmall cell lung cancer. Korean J Intern Med 7:118–121

    PubMed  Google Scholar 

  39. Lei KIK, Wickham NWR, Johnson PJ (1995) Severe hyponatremia due to syndrome of inappropriate secretion of antidiuretic hormone in a patient receiving interferon-alpha for chronic myeloid leukemia (letter). Am J Hematol 49:100

    Google Scholar 

  40. Levin L, Sealy R, Barron J (1982) Syndrome of inappropriate antidiuretic hormone secretion following cis-dichlorodiammineplatinum Il in a patient with malignant thymoma. Cancer 50:2279–2282

    PubMed  Google Scholar 

  41. Mariette X, Paule B, Bennet P, Clerc D, Bisson M, Massias P (1988) Cisplatin and hyponatremia (letter). Ann Intern Med 108:770–771

    Google Scholar 

  42. McCarron MO, Wright GD, Roberts SD (1995) Water intoxication after low dose cyclophosphamide. BMJ 311:292

    Google Scholar 

  43. Mead GM, Arnold AM, Green JA, Macbeth FR, Williams CJ, Whitehouse JM (1982) Epileptic seizures associated with cisplatin administration. Cancer Treat Rep 66:1719–1722

    PubMed  Google Scholar 

  44. Meriwether WD (1971) Vincristine toxicity with hyponatremia and hypochloremia in an adult. Oncology 25:234–238

    PubMed  Google Scholar 

  45. Moses AM, Miller M (1974) Drug-induced dilutional hyponatremia. N Engl J Med 291:1234–1239

    PubMed  Google Scholar 

  46. Murray JL, Cunningham JE, Brewer H, Mujoo K, Zukiwski AA, Podoloff DA, Kasi LP, Bhadkamkar V, Fritsche HA, Benjamin RS, Legha SS, Ater JL, Jaffe N, Itoh K, Ross MI, Bucana CD, Thompson L, Cheung L, Rosenblum MG (1994) Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors. J Clin Oncol 12:184–193

    PubMed  Google Scholar 

  47. Musch W, Thimpont J, Vandervelde D, Verhaeverbeke I, Berghmans T, Decaux G (1995) Combined fraction al excretion of sodium and urea better predicts response to saline in hyponatremia than do usual clinical and biochemical parameters. Am J Med 99:348–355

    PubMed  Google Scholar 

  48. Orbo A, Simonsen E (1992) Cisplatin-induced sodium and magnesium wastage. Eur J Cancer 28A:1294

    Google Scholar 

  49. Porter AT (1985) Syndrome of inappropriate antidiuretic hormone secretion during cis-dichlorodiammineplatinum therapy in a patient with an ovarian carcinoma. Gynecol Oncol 21:103–105

    PubMed  Google Scholar 

  50. Pratt CB, Douglass EC, Kovnar EH, Heideman R, Kun L, Avery L, Kellie SJ (1993) A phase I study of ifosfa mide given on alternate days to treat children with brain tumors. Cancer 71:3666–3669

    PubMed  Google Scholar 

  51. Quesada JR, Talpaz M, Rios A, Kurzrock R, Gutterman JU (1986) Clinical toxicity of interferons in cancer patients: a review. J Clin Oncol 4:234–243

    PubMed  Google Scholar 

  52. Ravikumar TS, Grage TB (1983) The syndrome of inappropriate ADH secretion secondary to vinblastine-bleo mycin therapy. J Surg Oncol 24:242–245

    PubMed  Google Scholar 

  53. Ribeiro RC, Rill D, Roberson PK, Furman WL, Pratt CB, Brenner M, Crist WM, Pui CH (1993) Continuous infusion of interleukin-2 in children with refractory malignancies. Cancer 72:623–628

    PubMed  Google Scholar 

  54. Ritch PS (1988) Cis-dichlorodiammineplatinum II-induced syndrome of inappropriate secretion of antidiuretic hormone. Cancer 61:448–450

    PubMed  Google Scholar 

  55. Robertson GL, Bhoopalam N, Zelkowitz LJ (1973) Vincristine neurotoxicity and abnormal secretion of anti diuretic hormone. Arch Intern Med 132:717–720

    PubMed  Google Scholar 

  56. Rufener C, Nordmann J, Rouiller C (1972) Effet de la vincristine sur l'hypophyse postérieure de rat in vitro. Neurochirurgie 18:137–141

    Google Scholar 

  57. Saleh MN, Khazaeli MB, Wheeler RH, Dropcho E, Liu T, Urist M, Miller DM, Lawson S, Dixon P, Russell CH, LoBuglio AF (1992) Phase I trial of the murine monoclonal antiGD2 antibody 14G2a in metastatic melanoma. Cancer Res 52:4342–4347

    PubMed  Google Scholar 

  58. Sandborn WJ, Gross JB Jr, Larson DE, Phillips JK, Lindor KD (1993) High volume postobstructive choleresis after transhepatic external biliary drainage resolves with conversion to internal drainage. J Clin Gastroenterol 17:42–45

    PubMed  Google Scholar 

  59. Santana VM, Schell MJ, Williams R, Bowman LC, Thompson EI, Brenner MK, Mirro J Jr (1992) Escalating sequential high dose carboplatin and etoposide with autologous marrow support in children with relapsed solid tumors. Bone Marrow Transplant 10:457–462

    PubMed  Google Scholar 

  60. Slater LM, Wainer RA, Serpick AA (1969) Vincristine neurotoxicity with hyponatremia. Cancer 23:122–125

    PubMed  Google Scholar 

  61. Sorensen JB, Andersen MK, Hansen HH (1995) Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease. J Intern Med 238:97–110

    PubMed  Google Scholar 

  62. Stuart MJ, Cuaso C, Miller M, Oski FA (1975) Syndrome of recurrent increased secretion of antidiuretic hormone following multiple doses of vincristine. Blood 45:315–320

    PubMed  Google Scholar 

  63. Suskind RM, Brusilow SW, Zehr J (1972) Syndrome of inappropriate secretion of antidiuretic hormone produced by vincristine toxicity (with bioassay of ADH level). J Pediatr 81:90–92

    PubMed  Google Scholar 

  64. Tak PP, Diamant Z (1993) Hyponatremia, hyperkaliemia and hypercalcemia after ileal conduit diversion. Scand J Urol Nephrol 27:271–274

    PubMed  Google Scholar 

  65. Takacs FJ (1975) Fluid and electrolyte problems in patients with advanced carcinoma. Med Clin North Am 59:449–457

    PubMed  Google Scholar 

  66. Tauzin-Fin P, Sanz L (1992) Le syndrome de résection transuréthrale de la prostate. Ann Fr Anesth Reanim 11:168–177

    PubMed  Google Scholar 

  67. Tomita M, Suzuki H, Matsuoka Y, Sakurada N (1981) Increased renal kallikrein excretion in SIADH after vincristine therapy. Endocrinol Jpn 28:637–641

    PubMed  Google Scholar 

  68. Tomwa K, Mikawa H, Hazama F, Yazawa K, Hosoya R, Ohya T, Nishimura K (1983) Syndrome of inappropriate secretion of antidiuretic hormone caused by vincristine therapy: a case report of the neuropathology. J Neurol 229:267–272

    PubMed  Google Scholar 

  69. Tscherning C, Rubie H, Chancholle A, Claeyssens S, Robert A, Fabre J, Bouissou F (1994) Recurrent renal salt wasting in a child treated with carboplatin and etoposide. Cancer 73:1761–1763

    PubMed  Google Scholar 

  70. Tweedy CR, Silverberg DA, Scott L (1992) Levamisole-induced syndrome of inappropriate antidiuretic hormone. N Engl J Med 326:1164

    PubMed  Google Scholar 

  71. Tzortzatou F, Dacou-Voutetakis C, Haidas S, Papadellis F, Thomaidis TH (1979) Electrolyte abnormalities in lymphosarcoma after chemotherapy. Acta Paediatr Scand 68:621–623

    PubMed  Google Scholar 

  72. Uy QL, Moen TH, Johns RH, Owens AH (1967) Vincristine neurotoxicity in rodents. Johns Hopkins Med J 121:349–360

    PubMed  Google Scholar 

  73. Vassal G, Rubie H, Kalifa C, Hartmann O, Lemerle J (1987) Hyponatremia and renal sodium wasting in patients receiving cisplatinum. Pediatr Hematol Oncol 4:337–344

    PubMed  Google Scholar 

  74. Vaswani SK, Sprague R (1993) Pseudohyponatremia in multiple myeloma. South Med J 86:251–252

    PubMed  Google Scholar 

  75. Vernant JP, Mouchnino G, Brun B, Reyes F, Kuentz M, Rochant H, Dreyfus B (1978) Les hyponatrémies au cours des leucémies aiguës. Ann Med Interne (Paris) 129:137–140

    Google Scholar 

  76. Wakem CJ, Bennett JM (1975) Inappropriate ADH secretion associated with massive vincristine overdosage. Aust NZ J Med 5:266–269

    Google Scholar 

  77. Webberley MJ, Murray JA (1989) Life-threatening acute hyponatraemia induced by low dose cyclophosphamide and indomethacin. Postgrad Med J 65:950–952

    PubMed  Google Scholar 

  78. Welborn J, Meyers FJ, O'Grady LF (1988) Renal salt wasting and carboplatinum (letter). Ann Intern Med 108:640

    Google Scholar 

  79. White MG, Fewer CD (1975) Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with lithium carbonate. N Engl J Med 292:390–392

    PubMed  Google Scholar 

  80. Whittaker JA, Parry DH, Bunch C, Weatherall DJ (1973) Coma associated with vincristine therapy. BMJ 4:335–337

    PubMed  Google Scholar 

  81. Zavagli G, Ricci G, Tataranni G, Mapelli G, Abbasciano V (1988) Lifethreatening hyponatremia caused by vinblastine. Med Oncol Tumor Pharmacother 5:67–69

    PubMed  Google Scholar 

Download references

Author information

Author notes

  1. T. Berghmans M.D.

    Present address: Department of Infectious Disease, Centre Hospitalier Universitaire Vaudois, CH-1011, Lausanne, Switzerland

Authors and Affiliations

  1. Department of Internal Medicine, Institut Jules Bordet, 1, Rue Héger-Bordet, B-1000, Brussels, Belgium

    T. Berghmans M.D.

Authors
  1. T. Berghmans M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berghmans, T. Hyponatremia related to medical anticancer treatment. Support Care Cancer 4, 341–350 (1996). https://doi.org/10.1007/BF01788840

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01788840

Key words

Search

Navigation